Reneuron Group (RENE)

 

Latest News

Director Share Purchase

RNS Number: 8537R ReNeuron Group plc 14 December 2016 14 December 2016 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Director Share Purchase ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, was informed on 14 December 2016 that, on the same day, Olav Helleb, the Company'...

ReNeuron widens H1 pretax loss

ReNeuron has widened its H1 pretax loss to 8.6m, from a loss of 5.2m. Revenue was 22,000, from 11,000. Research and develo...

ReNeuron reports positive results in Phase II Stroke Trial

ReNeuron Group announces positive data from its Phase II clinical trial (PISCES II) of its CTX cell therapy candidate for s...

Reports Positive Results in Phase II Stroke Trial

RNS Number: 8916Q ReNeuron Group plc 05 December 2016 5 December 2016 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Reports positive results in Phase II stroke trial ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce positive data from the Company's Phase II ...

All News

DateHeadlineSource
14-12-16Director Share PurchaseRNS
05-12-16ReNeuron widens H1 pretax lossStockMarketWire
05-12-16ReNeuron reports positive results in Phase II Stroke TrialStockMarketWire
05-12-16Interim ResultsRNS
05-12-16Reports Positive Results in Phase II Stroke TrialRNS
14-11-16Notification of Interim ResultsRNS
14-10-16ReNeuron Group Plc to present at the Shares Investor Evening in London on 27th October 2016StockMarketWire
05-10-16Notification of Major Interest in SharesRNS
22-09-16Block Listing Review and Total Voting RightsRNS
06-09-16ReNeuron passes AGM resolutionsStockMarketWire
06-09-16Result of AGMRNS
06-09-16AGM Trading UpdateRNS
05-08-16Posting of Annual Report and Notice of AGMRNS
04-08-16Stroke clinical data published in The LancetRNS
22-07-16Publication of positive pre-clinical retinal dataRNS
20-07-16Directors' Interest in Shares and Share OptionsRNS
07-07-16Preliminary ResultsRNS
14-06-16Notification of Preliminary ResultsRNS
13-06-16Reuron says patient recruitment completed in stroke trial StockMarketWire
13-06-16Patient recruitment completed in stroke trialRNS
09-06-16ReNeuron pursues brain cancer with exosome platform StockMarketWire
09-06-16Pursues brain cancer with exosome platformRNS
08-06-16ReNeuron Group gives Retinitis pigmentosa update StockMarketWire
08-06-16Retinitis pigmentosa update & Notice of KOL eventRNS
31-05-16Change of AdviserRNS
21-03-16Are Today’s Double-Digit Rises Just The Start For Filtronic Plc, Angle plc And ReNeuron Group Plc?Motley Fool
15-03-16RENE says first patient treated in RP clinical trial StockMarketWire
15-03-16First Patient Treated in RP Clinical TrialRNS
23-02-16ReNeuron Relocates to South WalesRNS
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director Deals - ReNeuron Group PLC (RENE)StockMarketWire
17-02-16Director's DealingsRNS
03-02-16Director Share PurchaseRNS
01-02-16ReNeuron granted key US patentStockMarketWire
01-02-16Notice of Grant of Key US PatentRNS
12-01-16Pre-clinical data relating to exosome platformRNS
11-01-16ReNeuron wins major grantStockMarketWire
11-01-16Wins UK grant to advance its exosome platformRNS
17-12-15ReNeuron establishes Scientific Advisory BoardRNS

RSS feeds

  • Editorial news feed for LSE:RENE Editorial
  • Regulatory news feed for LSE:RENE Regulatory